| Literature DB >> 18289064 |
E Xirouchakis1, A Sigalas, P Manousou, V Calvaruso, M Pleguezuelo, A Corbani, S Maimone, D Patch, A K Burroughs.
Abstract
Non alcoholic fatty liver disease (NAFLD) is often part of the metabolic syndrome which includes central obesity, dyslipidaemia, insulin resistance/type 2 diabetes mellitus and hypertension. In turn, NAFLD may be associated with an increased vascular risk. Several experimental models which express histological steatosis or steatohepatitis with fibrosis have been described. This review identifies those models of NAFLD with features of vascular risk.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18289064 DOI： 10.2174/138161208783497705
Source DB: PubMed Journal: Curr Pharm Des ISSN： 1381-6128 Impact factor: 3.116